Bavarian lands monkeypox vaccine contract with unnamed European country
On Thursday, as more monkeypox cases emerge across Europe, Bavarian Nordic has announced a supply contract with an undisclosed European country for its vaccine Imvanex.
by andreas lønstrup, translated by daniel pedersen
In the face of a small European outbreak of monkeypox, with the UK, Portugal, and Spain reporting confirmed cases, Bavarian Nordic has signed a contract to supply its vaccine against the infection to an undisclosed country in Europe, the company has announced in a Thursday press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
